These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 10446394

  • 1. Troglitazone inhibits expression of the phosphoenolpyruvate carboxykinase gene by an insulin-independent mechanism.
    Davies GF, Khandelwal RL, Roesler WJ.
    Biochim Biophys Acta; 1999 Aug 12; 1451(1):122-31. PubMed ID: 10446394
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of phosphoenolpyruvate carboxykinase (PEPCK) gene expression by troglitazone: a peroxisome proliferator-activated receptor-gamma (PPARgamma)-independent, antioxidant-related mechanism.
    Davies GF, Khandelwal RL, Wu L, Juurlink BH, Roesler WJ.
    Biochem Pharmacol; 2001 Oct 15; 62(8):1071-9. PubMed ID: 11597575
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Effect of troglitazone (Rezulin) on fructose 2,6-bisphosphate concentration and glucose metabolism in isolated rat hepatocytes.
    Raman P, Foster SE, Stokes MC, Strenge JK, Judd RL.
    Life Sci; 1998 Oct 15; 62(8):PL89-94. PubMed ID: 9489515
    [Abstract] [Full Text] [Related]

  • 6. Role of glucose and insulin in thiazolidinedione-induced alterations in hepatic gluconeogenesis.
    Raman P, Judd RL.
    Eur J Pharmacol; 2000 Dec 01; 409(1):19-29. PubMed ID: 11099696
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Troglitazone inhibits fatty acid oxidation and esterification, and gluconeogenesis in isolated hepatocytes from starved rats.
    Fulgencio JP, Kohl C, Girard J, Pégorier JP.
    Diabetes; 1996 Nov 01; 45(11):1556-62. PubMed ID: 8866561
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Novel aspects in the mechanisms of steroid diabetes and the regulation of hepatic glucose production by insulin and steroids].
    Barthel A, Scherbaum WA, Bornstein SR.
    Med Klin (Munich); 2003 Apr 25; 98(5):283-6. PubMed ID: 12721674
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Sodium meta-arsenite ameliorates hyperglycemia in obese diabetic db/db mice by inhibition of hepatic gluconeogenesis.
    Lee YS, Lee EK, Oh HH, Choi CS, Kim S, Jun HS.
    J Diabetes Res; 2014 Apr 25; 2014():961732. PubMed ID: 25610880
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Comparison of the metabolic effects of metformin and troglitazone on fructose-induced insulin resistance in male Sprague-Dawley rats.
    Chen CC, Wang HJ, Shih HC, Sheen LY, Chang CT, Chen RH, Wang TY.
    J Formos Med Assoc; 2001 Mar 25; 100(3):176-80. PubMed ID: 11393112
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. UCP3 gene expression does not correlate with muscle oxidation rates in troglitazone-treated Zucker fatty rats.
    Oberkofler H, Neschen S, Esterbauer H, Waldhäusl W, Patsch W, Fürnsinn C.
    Biochim Biophys Acta; 2000 Dec 15; 1517(1):113-8. PubMed ID: 11118623
    [Abstract] [Full Text] [Related]

  • 20. Troglitazone prevents hyperglycemia-induced but not glucosamine-induced insulin resistance.
    Miles PD, Higo K, Romeo OM, Lee MK, Rafaat K, Olefsky JM.
    Diabetes; 1998 Mar 15; 47(3):395-400. PubMed ID: 9519745
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.